Halozyme Therapeutics Inc. announced that the company is commencing, through wholly owned subsidiary Atlas Merger Sub Inc., a cash tender offer to purchase all outstanding shares of common stock of Antares Pharma Inc. for $5.60 per share in cash.

Abbott received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) to purchase up to 1,000,000 Abbott common shares, representing approximately 0.06% of the company’s outstanding shares.